Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Squamous Cell Carcinoma of Head”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02643550
What this trial is testing

Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Neoplasms
Innate Pharma 143
Testing effectiveness (Phase 2)Looking for participantsNCT07290010
What this trial is testing

The Efficacy and Safety of Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy as the First-line Treatment for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Hebei Medical University Fourth Hospital 25
Testing effectiveness (Phase 2)Study completedNCT00076310
What this trial is testing

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)WithdrawnNCT00934518
What this trial is testing

Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Cancer of the Head and Neck
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT04671667
What this trial is testing

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT00898664
What this trial is testing

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT03383094
What this trial is testing

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaCancerCancer of Head and Neck+12 more
Loren Mell, MD 126
Not applicableLooking for participantsNCT05047094
What this trial is testing

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaSkin CancerMetastatic Head-and-neck Squamous-cell Carcinoma
Alpha Tau Medical LTD. 48
Not applicableStudy completedNCT00984074
What this trial is testing

MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Abramson Cancer Center at Penn Medicine 3
Testing effectiveness (Phase 2)Study completedNCT00358930
What this trial is testing

ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60
Large-scale testing (Phase 3)Study completedNCT05523323
What this trial is testing

Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03162224
What this trial is testing

Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerHuman Papilloma Virus
MedImmune LLC 35
Testing effectiveness (Phase 2)Looking for participantsNCT05283226
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

Who this might be right for
CarcinomaRecurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
NATCO Pharma Ltd. 21
Not applicableLooking for participantsNCT06356272
What this trial is testing

Oropharynx (OPX) Biomarker Trial

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell Carcinoma+8 more
Mayo Clinic 560
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751289
What this trial is testing

Anti-PD-1 Therapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell Carcinoma
Yanjie Zhang, MD 217
Testing effectiveness (Phase 2)Study completedNCT01252628
What this trial is testing

Phase 1 and 2 Study of PX-866 and Cetuximab

Who this might be right for
Incurable Metastatic Colorectal CarcinomaIncurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cascadian Therapeutics Inc. 178
Testing effectiveness (Phase 2)Ended earlyNCT00872404
What this trial is testing

CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

Who this might be right for
Head and Neck Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 37
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 680
Next Page
188